JFG
AUPH icon

Jefferies Financial Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Jefferies Financial Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40,000
Closed -$359K – 1615
2024
Q4 		$359K Hold
40,000
– – ﹤0.01% 1207
2024
Q3 		$293K Buy
+40,000
New +$248K ﹤0.01% 1125

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jefferies Financial Group's AUPH Position: Q1 2025 in Review

Jefferies Financial Group sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2025, closing a stake of 8,587 shares — an estimated $77.1K sold.

Jefferies Financial Group first reported a position in AUPH in Q1 2023 and held it in 5 quarters. The position peaked at $2.19M in Q1 2023. 214 funds tracked by Wall St. Rank hold AUPH as of Q1 2025.

  • Jefferies Financial Group reported no remaining Aurinia Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 8,587 Aurinia Pharmaceuticals shares in Q1 2025, an estimated $77.1K.
  • Jefferies Financial Group first reported a position in Aurinia Pharmaceuticals in Q1 2023 and held it in 5 quarters.
  • Jefferies Financial Group's Aurinia Pharmaceuticals position peaked at $2.19M in Q1 2023.
  • 214 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2025.

Based on Jefferies Financial Group's 13F filing for Q1 2025, filed 8 May 2025.